依诺昔酮
| 中文名称 | 依诺昔酮 |
|---|---|
| 中文同义词 | 1,3-二氢-4-甲基-5-(4-甲硫基苯甲酰基)-2H-咪唑-2-酮;依诺昔酮;氢甲苯咪酮;伊诺西酮;伊诺昔酮;1,3-二氢-4-甲基-5-(4-甲基硫代苯甲酰)-2H-咪唑-2-酮;烯氟酮;4-甲基-5-(4-(甲硫基)苯甲酰基)-1H-咪唑-2(3H)-酮 |
| 英文名称 | Enoximone |
| 英文同义词 | ENOXIMONE;2H-Imidazol-2-one, 1,3-dihydro-4-methyl-5-(4-(methylthio)benzoyl)-;Fenoximone;MDL-17043;Pedane;Perfan;RMI-17043;4-methyl-5-(4-methylsulfanylbenzoyl)-1,3-dihydroimidazol-2-one |
| CAS号 | 77671-31-9 |
| 分子式 | C12H12N2O2S |
| 分子量 | 248.3 |
| EINECS号 | |
| 相关类别 | 强心药;心脑血管药物;药物;原料药;APIs;API |
| Mol文件 | 77671-31-9.mol |
| 结构式 |  |
依诺昔酮 性质
| 熔点 | 255-258°C |
|---|---|
| 密度 | 1.33 |
| 储存条件 | Sealed in dry,Room Temperature |
| 溶解度 | DMSO：28 mg/mL，可溶 |
| 酸度系数(pKa) | 10.37±0.70(Predicted) |
| 形态 | 固体 |
| 颜色 | 浅黄色 |
| CAS 数据库 | 77671-31-9(CAS DataBase Reference) |
|
PDE3/PDE Ⅲ 5.9 μM (IC 50 ) |
PDE4A 21.1 μM (IC 50 , myocardial PDE4A) |
In vitro, 10 μM Enoximone-treated bronchoalveolar lavage (BAL) eosinophils induced by IL-33 treatment shows significantly lower CD11b expression when compared with diluent-treated BAL eosinophils.
Topical Enoximone (25 μg; intratracheal route) abrogates house dust mite (HDM)-induced allergic airway inflammation.
The Enoximone-treated (25 μg; for 5 days) HDM-exposed mice shows significant reductions in inflammatory cell numbers including eosinophils, macrophages, neutrophils, ILC2s, and T cells, indicating that Enoximone treatment reduces airway inflammation.
安全信息
| 危险品运输编号 | 3249 |
|---|---|
| WGK Germany | 3 |
| 危险等级 | 6.1(b) |
| 包装类别 | III |
| 提供商 | 语言 |
|---|---|
|
英文
|
|
|
英文
|
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2024/01/25 | HY-B1639 | Enoximone | 5 mg | 1000元 | |
| 2024/01/25 | HY-B1639 | 依诺昔酮 Enoximone | 77671-31-9 | 10mg | 1600元 |